Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-01-12FDA Approved: HEPARIN SODIUM — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for HEPARIN SODIUM from Sagent Pharmaceuticals, authorizing changes under an approved supplemental f…
-
FDA approval · 2022-01-12FDA Approved: HEPARIN SODIUM — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for Heparin Sodium from Sagent Pharmaceuticals, confirming regulatory status and updates related to …
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Postoperative Acute Myocardial Ischemic Injury [NA]
A clinical trial update for postoperative acute myocardial ischemic injury (Myocardial Infarction) from The Cleveland Clinic has been termin…
-
FDA approval · 2021-12-23FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for lisinopril submitted by Camber Pharmaceuticals, Inc., approving changes to the lisinopril pr…
-
FDA approval · 2021-12-21FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Limited. The action confirms approva…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: A Study of Acute Myocardial Infarction Using FDY-5301 [Phase 2]
Phase 2 study of FDY-5301 for acute myocardial infarction, including ST-elevation myocardial infarction; results were posted December 14, 20…
-
FDA approval · 2021-12-06FDA Approved: VALSARTAN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for valsartan submitted by Aurobindo Pharma Limited, updating the existing approval for this generic…
-
FDA approval · 2021-12-06FDA Approved: VALSARTAN — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for VALSARTAN from Macleods Pharmaceuticals Limited. This approval supports continued distribution o…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: China-Administration of Nicorandil Group（CHANGE） [Phase 4]
A Phase 4 clinical trial update from CHANGE assessed nicorandil in patients with myocardial infarction undergoing percutaneous coronary inte…
-
FDA approval · 2021-11-02FDA Approved: VALSARTAN — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original ANDA for valsartan, enabling generic manufacture and marketing of valsartan for its approved …
-
FDA approval · 2021-10-27FDA Approved: VALSARTAN — Original Application (ScieGen Pharmaceuticals, INC.)
FDA approves the original application for VALSARTAN (Valsartan) from ScieGen Pharmaceuticals as a generic angiotensin II receptor blocker. I…
-
FDA approval · 2021-10-25FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for metoprolol tartrate (generic beta-blocker), under an ANDA.
-
FDA approval · 2021-10-05FDA Approved: VALSARTAN — Original Application (Dr. Reddy's Laboratories Limited)
FDA approves the original application for valsartan from Dr. Reddy's Laboratories Limited, granting approval for the generic product.
-
FDA approval · 2021-10-01FDA Approved: RAMIPRIL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Ramipril from Rising Pharma Holdings, Inc., enabling the continued manufacture and distribut…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction [Phase 4]
Phase 4 trial comparing Sacubitril/Valsartan to Valsartan in hypertensive patients with acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Subclinical Cardiovascular Disease in Psoriatic Disease [Phase 4]
Phase 4 clinical trial update on subclinical cardiovascular disease in psoriatic disease; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis [Phase 4]
Phase 4 clinical trial assessing the effect of influenza vaccination on future cardiovascular prognosis after myocardial infarction.
-
FDA label_change · 2021-09-15FDA Approved: METOPROLOL — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for metoprolol tartrate products from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure [Phase 4]
A Phase 4 clinical trial update on an influenza vaccine aimed at reducing cardiovascular events in patients with heart failure and prior myo…
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study [Phase 1, Phase 2]
Clinical trial update for Rituximab in acute ST-elevation myocardial infarction (Phase 1/2) completed.
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury [Phase 4]
A Phase 4 randomized trial evaluating Shenfu Injection for reducing myocardial injury in myocardial infarction patients.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Sodium Thiosulfate to Preserve Cardiac Function in STEMI [Phase 2]
Phase 2 clinical trial evaluating sodium thiosulfate to preserve cardiac function after a myocardial infarction.
-
FDA approval · 2021-09-07FDA Approved: EPTIFIBATIDE — Original Application (Hainan Shuangcheng Pharmaceuticals Co., Ltd.)
The FDA approved the original ANDA for Eptifibatide from Hainan Shuangcheng Pharmaceuticals Co., Ltd., authorizing a generic version of the …
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus [Phase 3]
Phase 3 trial comparing apixaban to warfarin in patients with left ventricular thrombus is completed, evaluating anticoagulation strategy in…
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack [Phase 2]
Phase 2 clinical trial evaluating ACT-246475 in adults after acute myocardial infarction has completed, with results posted in 2021.